ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly

MONSEY, N.Y., July 28, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of AtaiBeckley, Inc. (Nasdaq: ATAI) (“AtaiBeckley”) to Eli Lilly and Company (“Lilly”), pursuant to which AtaiBeckley shareholders will receive $6.75 per share in cash, plus a contingent value right (“CVR”) worth up to an additional $2.50 per share.

Notably, the sale price with the CVR is well below the price targets of multiple Wall Street analysts covering AtaiBeckley before the sale was announced, including: * Patrick Trucchio of H.C. Wainwright ($25.00 price target) * Sumant Kulkarni of Canaccord Genuity ($17.00 price target) * Jay Olson of Oppenheimer ($16.00 price target) * Eddie Hickman of Guggenheim ($16.00 price target) * Harry Gillis of Berenberg Bank ($14.00 price target) (Source: TipRanks)